GGrantIndex
Sort

51,593 grants matching hepatitis

Nuclear envelope and predisposition to hepatic neoplasia

$384,860
Ji-Yeon Shin · Hackensack University Medical Center · R01 · FY2024 · CA

TET1 in non-alcoholic fatty liver disease development

$384,829
Chiung-Kuei Huang · Tulane University Of Louisiana · R01 · FY2025 · DK

Molecular Studies of Hepatitis C Virus.

$384,800
Suzanne U Emerson · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Oligosaccharides of Normal and Malignant Cells

$384,792
University Of California San Diego · R01 · FY2005 · CA

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$384,787
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2016 · DK

Regulation of Cholesterol Catabolism by Bile Acids

$384,780
Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2017 · DK

Hepatitis C Virus Trafficking in Infected Hepatocytes

$384,770
Glenn C Randall · University Of Chicago · R01 · FY2013 · AI

Taskforce for Obesity Research at Southwestern (TORS)

$384,760
Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2011 · DE

Inhibition of the Interferon Response by West Nile Virus

$384,750
Christoph Seeger · Research Inst Of Fox Chase Can Ctr · R01 · FY2007 · AI

In vitro modeling to characterize mechanisms of neonatal vaccine induced immune responses

$384,734
Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI

Biotransformation Gene-Environment Interactions in Coho Salmon Neurotoxicity

$384,687
Evan P Gallagher · University Of Washington · P42 · FY2007 · ES

Molecular basis of selective P450 2B function

$384,654
James R Halpert · University Of Connecticut Storrs · R01 · FY2015 · ES

Nuclear Receptor Functional Profiling in Metabolism and Disease

$384,630
Ronald M. Evans · Baylor College Of Medicine · U19 · FY2011 · DK

Investigating the Catalytic Mechanism of the HDV Ribozyme

$384,624
Joseph Anthony Piccirilli · University Of Chicago · R56 · FY2009 · AI

Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS

$384,609
John D Morrey · Utah State University · N01 · FY2014 · AI

Nucleoside Transporters: disposition of nucleoside drugs

$384,547
University Of Washington · R01 · FY2005 · GM

Hepatic Stellate Cell Activation induced by HCV

$384,531
Columbia University Health Sciences · R01 · FY2005 · AA

The Musculoskeletal Cost of Organ Repair

$384,518
Leonidas G Koniaris · Oregon Health & Science University · R01 · FY2023 · GM

INNATE IMMUNE DEFENSE AGAINST HCV and HIV: THE CHIMERIC MOUSE MODEL

$384,477
Michael J Gale · University Of Washington · R01 · FY2009 · DA

Project 2 - Mechanisms of Hepatitis B Virus Replication

$384,453
Daniel D Loeb · University Of Wisconsin-Madison · P01 · FY2021 · CA

RNAi for the Treatment of Viral Hepatitis

$384,442
Mark A Kay · Stanford University · R01 · FY2007 · AI

Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease

$384,442
Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2014 · HL

Exercise and Fuel Metabolism

$384,438
David H Wasserman · Vanderbilt University · R37 · FY2008 · DK

Longitudinal cohort of newly acquired HCV infection

$384,435
Natl Centre/Hiv Epidemiology/Clncl Res · R01 · FY2004 · DA

Reprogramming of liver cell fate by Hippo signaling

$384,431
Fernando Camargo · Boston Children'S Hospital · R01 · FY2015 · DK